SAWT BEIRUT INTERNATIONAL

| 30 May 2024, Thursday |

AstraZeneca COVID drug neutralizes Omicron sub-variants in lab study

AstraZeneca said its antibody-based cocktail to prevent and treat COVID-19 retained neutralizing activity against Omicron coronavirus variants, including the highly contagious BA.2 sub-variant, in an independent lab study.

    Source:
  • Reuters